APOB and depressive disorder: Mechanistically, ApoB-containing atherogenic lipoproteins may promote endothelial dysfunction and microvascular injury, amplify systemic inflammation and lipid peroxidation, and perturb monoaminergic signaling and neuroplasticity—pathways long implicated in depression.